|
1
|
Kim HJ and Oh SC: Novel systemic therapies
for advanced gastric cancer. J Gastric Cancer. 18:1–19. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An Attempt At A Histo-Clinical Classification. Acta
Pathol Microbio Scand. 64:31–49. 1965. View Article : Google Scholar
|
|
3
|
Hamilton SR and Aaltonen LA: World Health
Organization Classification of Tumours. Pathology and Genetics of
Tumours of the Digestive System. IARC Press; Lyon, France: 2000
|
|
4
|
Cisło M, Filip AA, Arnold Offerhaus GJ,
Ciseł B, Rawicz-Pruszyński K, Skierucha M and Polkowski WP:
Distinct molecular subtypes of gastric cancer: From Laurén to
molecular pathology. Oncotarget. 9:19427–19442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren D, Lin B, Zhang X, Peng Y, Ye Z, Ma Y,
Liang Y, Cao L, Li X, Li R, et al: Maintenance of cancer stemness
by miR-196b-5p contributes to chemoresistance of colorectal cancer
cells via activating STAT3 signaling pathway. Oncotarget.
8:49807–49823. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fry AM, O'Regan L, Sabir SR and Bayliss R:
Cell cycle regulation by the NEK family of protein kinases. J Cell
Sci. 125:4423–4433. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moniz L, Dutt P, Haider N and Stambolic V:
Nek family of kinases in cell cycle, checkpoint control and cancer.
Cell Div. 6:182011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prosser SL, O'Regan L and Fry AM: Novel
insights into the mechanisms of mitotic spindle assembly by NEK
kinases. Mol Cell Oncol. 3:e10629522015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jackson PK: Nek8 couples renal
ciliopathies to DNA damage and checkpoint control. Mol Cell.
51:407–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Otto EA, Trapp ML, Schultheiss UT, Helou
J, Quarmby LM and Hildebrandt F: NEK8 mutations affect ciliary and
centrosomal localization and may cause nephronophthisis. J Am Soc
Nephrol. 19:587–592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sohara E, Luo Y, Zhang J, Manning DK,
Beier DR and Zhou J: Nek8 regulates the expression and localization
of polycystin-1 and polycystin-2. J Am Soc Nephrol. 19:469–476.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi HJ, Lin JR, Vannier JB, Slaats GG,
Kile AC, Paulsen RD, Manning DK, Beier DR, Giles RH, Boulton SJ and
Cimprich KA: NEK8 links the ATR-regulated replication stress
response and S phase CDK activity to renal ciliopathies. Mol Cell.
51:423–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holland PM, Milne A, Garka K, Johnson RS,
Willis C, Sims JE, Rauch CT, Bird TA and Virca GD: Purification,
cloning, and characterization of Nek8, a novel NIMA-related kinase,
and its candidate substrate Bicd2. J Biol Chem. 277:16229–16240.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grampa V, Delous M, Zaidan M, Odye G,
Thomas S, Elkhartoufi N, Filhol E, Niel O, Silbermann F, Lebreton
C, et al: Novel NEK8 mutations cause severe syndromic renal cystic
dysplasia through YAP dysregulation. PLoS Genet. 12:e10058942016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valkova N, Yunis R, Mak SK, Kang K and
Kültz D: Nek8 mutation causes overexpression of galectin-1, sorcin,
and vimentin and accumulation of the major urinary protein in renal
cysts of jck mice. Mol Cell Proteomics. 4:1009–1018. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frank V, Habbig S, Bartram MP, Eisenberger
T, Veenstra-Knol HE, Decker C, Boorsma RA, Göbel H, Nürnberg G,
Griessmann A, et al: Mutations in NEK8 link multiple organ
dysplasia with altered Hippo signalling and increased c-MYC
expression. Hum Mol Genet. 22:2177–2185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abeyta A, Castella M, Jacquemont C and
Taniguchi T: NEK8 regulates DNA damage-induced RAD51 foci formation
and replication fork protection. Cell Cycle. 16:335–347. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Czarnecki PG, Gabriel GC, Manning DK,
Sergeev M, Lemke K, Klena NT, Liu X, Chen Y, Li Y, San Agustin JT,
et al: ANKS6 is the critical activator of NEK8 kinase in embryonic
situs determination and organ patterning. Nat Commun. 6:60232015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding XF, Zhou J, Hu QY, Liu SC and Chen G:
The tumor suppressor pVHL down-regulates never-in-mitosis A-related
kinase 8 via hypoxia-inducible factors to maintain cilia in human
renal cancer cells. J Biol Chem. 290:1389–1394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gossage L, Eisen T and Maher ER: VHL, the
story of a tumour suppressor gene. Nat Rev Cancer. 15:55–64. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bowers AJ and Boylan JF: Nek8, a NIMA
family kinase member, is overexpressed in primary human breast
tumors. Gene. 328:135–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li M and Kim WY: Two sides to every story:
The HIF-dependent and HIF-independent functions of pVHL. J Cell Mol
Med. 15:187–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
